In human tissue, TDP‐43 has been observed to colocalise with hyperphosphorylated tau and amyloid‐β, and in animal models of AD, it was found to impact disease progression by decreasing the expression of calcineurin, which is inversely associated with Braak stages [19]. Here, TARDBP is linked to Alzheimer disease.